Australia develops quantum biotech platform to transform Alzheimer's treatment discovery

A University of Melbourne industry collaboration has been awarded $2.1 million by the Australian Government to build a q...

March 4, 2026 | Wednesday | News
Mission (im)possible? Efficient Global Antibody Drug Conjugate Product Approvals

ADCs are highly complex molecules that were initially developed to allow highly potent cytotoxic agents to be selectivel...

March 1, 2026 | Sunday | Opinion
“The global trend is moving beyond centralised hubs toward distributed networks and domestic capability”

As Saudi Arabia accelerates its biotech ambitions, what specific infrastructure investments or technological advancement...

March 1, 2026 | Sunday | Opinion
“We believe Korea outpaces many Western markets in its appetite and readiness to adopt integrated digital-biological innovation”

What strategic gaps in the Korean diagnostics market does this exclusive distribution agreement with Lucent Diagnostics ...

March 1, 2026 | Sunday | Opinion
“Asia is a growth engine, and India is a cornerstone of that strategy — both as a destination for advanced therapies and as a contributor to global innovation”

How is Miltenyi Biotec adapting its long-term strategy to meet the specific scientific and clinical demands of ASEAN mar...

March 1, 2026 | Sunday | Opinion
China's Frontier Biotech inks $963 M deal with GSK for small interfering RNA therapeutics

China-based Frontier Biotechnologies Inc. has entered into an exclusive licensing agreement with GSK, a global biop...

February 27, 2026 | Friday | News
Japan's Asahi Kasei acquires Germany's Aicuris for €780 M

Aicuris Anti-infective Cures AG has entered into a definitive agreement under which Japan's Asahi Kasei, through it...

February 27, 2026 | Friday | News
EU supports SK bioscience, IDT Biologika and Vaxxas for next-generation influenza vaccine development

South Korea-based SK bioscience has announced that together with IDT Biologika (IDT) and Australian biotechnology compan...

February 26, 2026 | Thursday | News
Hong Kong, Sweden collaboration to advance mesenchymal stromal cell therapy for knee osteoarthritis

The InnoHK Centre for Neuromusculoskeletal Restorative Medicine (CNRM), established by The Chinese University of Hong Ko...

February 26, 2026 | Thursday | News
YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform

YD Bio Limited, biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic inn...

February 26, 2026 | Thursday | News
Sarepta Therapeutics announces commercial launch of ELEVIDYS in Japan for DMD treatment

US-based Sarepta Therapeutics, Inc. has announced the commercial launch of ELEVIDYS (delandistrogene moxeparvovec) in Ja...

February 25, 2026 | Wednesday | News
Europe At A Biotech Crossroads As Digital Gaps Challenge Global Ambitions

In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, ...

February 25, 2026 | Wednesday | News
Japan's Astellas announces $1.37 B deal with Vir Biotechnology to develop T-Cell therapies for prostate cancer

Japan-based Astellas Pharma and US-based startup Vir Biotechnology have entered into a global strategic collaboration to...

February 24, 2026 | Tuesday | News
Sciwind Biosciences partners with Pfizer China to commercialise Biased GLP-1 in China in $495 M deal

Hangzhou Sciwind Biosciences has announced a strategic commercialisation collaboration with Pfizer China for Ecnoglutide...

February 24, 2026 | Tuesday | News
ImmunityBio to launch ANKTIVA® in Saudi Arabia for bladder and lung cancer treatment

ImmunityBio, Inc., a commercial-stage immunotherapy company based in the US, has announced a partnership with Biopharma ...

February 20, 2026 | Friday | News
Korea's S.Biomedics announces partnership with Catalent to develop and manufacture TED‑A9

US-based Catalent and South Korea-based S.Biomedics have announced a strategic partnership to support the development an...

February 19, 2026 | Thursday | News
Johnson & Johnson expands US footprint with more than $1 B investment in next gen cell therapy manufacturing facility

Johnson & Johnson has announced more than $1 billion investment in a next generation cell therapy manufacturing faci...

February 19, 2026 | Thursday | News
Dr Jitendra Singh calls for Mission-based India-Australia technical cooperation

After talks between India's Union Minister for Science and Technology (S&T) Dr Jitendra Singh and Australian&nb...

February 19, 2026 | Thursday | News
AusBiotech & Proto Axiom launch national investor-focused life sciences partnership in Australia

AusBiotech and Sydney‑based life sciences company creator Proto Axiom have signed a Memorandum of  Understan...

February 19, 2026 | Thursday | News
Korea supports rapid growth of biopharma companies through global collaboration

The Ministry of Health and Welfare (MoHW), South Korea government, and the Korea Health Industry Development Institute (...

February 18, 2026 | Wednesday | News
CARsgen invests RMB 370 M to expand CAR-T commercial manufacturing base in Shanghai

CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that through its in...

February 13, 2026 | Friday | News
Madrigal expands MASH pipeline with siRNA therapies in $4.4 B deal

Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...

February 12, 2026 | Thursday | News
Takeda and Iambic ink $1.7 B deal to advance AI driven design of small molecules

Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial in...

February 11, 2026 | Wednesday | News
Japan's Saisei Ventures launches bridge-to-biotech venture creation initiative

Saisei Ventures, a pioneering investment firm focused on advancing Japanese biotechnology and therapeutic innovations gl...

February 10, 2026 | Tuesday | News
Innovent inks $8.5 B deal with Eli Lilly for oncology and immunology based medicines

China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...

February 10, 2026 | Tuesday | News